Alexion Pharmaceuticals, Inc.

Robeco Institutional Asset Management B.V. ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

12/1/2022

Shares

61,756

Value ($000)

11,345

Weight

0.0%

2013 Q4 - 2021 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	12/1/2022	11,345	0.0%	61,756	6/30/2021
2021 Q1	12/1/2022	14,018	0.0%	91,678	3/31/2021
2020 Q4	12/1/2022	23,888	0.1%	152,908	12/31/2020
2020 Q3	1/19/2021	24,778	0.1%	216,537	9/30/2020
2020 Q2	1/19/2021	7,093	0.0%	63,187	6/30/2020
2020 Q1	1/19/2021	6,113	0.0%	68,079	3/31/2020
2019 Q4	1/19/2021	12,375	0.0%	114,430	12/31/2019
2019 Q3	1/19/2021	11,950	0.0%	122,031	9/30/2019
2019 Q2	1/19/2021	10,250	0.0%	78,273	6/30/2019
2019 Q1	1/19/2021	8,442	0.0%	62,458	3/31/2019
2018 Q4	1/19/2021	4,603	0.0%	47,290	12/31/2018
2018 Q3	1/19/2021	6,074	0.0%	43,692	9/30/2018
2018 Q2	1/19/2021	1,975	0.0%	15,910	6/30/2018
2018 Q1	1/19/2021	1,774	0.0%	15,933	3/31/2018
2017 Q4	1/19/2021	1,908	0.0%	15,980	12/31/2017
2017 Q3	1/19/2021	1,489	0.0%	10,605	9/30/2017
2017 Q2	1/19/2021	1,198	0.0%	9,850	6/30/2017
2017 Q1	1/19/2021	131	0.0%	1,070	3/31/2017
2014 Q1	5/7/2014	1,212	0.0%	7,966	3/31/2014
2013 Q4	2/4/2014	155	0.0%	1,168	12/31/2013